Literature DB >> 20556232

Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.

Nicole J Barshop1, Cameron S Francis, Jeffrey B Schwimmer, Joel E Lavine.   

Abstract

Childhood obesity is a worldwide health problem associated with an increase in the prevalence and severity of comorbid conditions including nonalcoholic fatty liver disease (NAFLD). The increasing number of children with NAFLD presents a major public health concern. This review focuses on the recent advancements in the understanding of the epidemiology, diagnosis, histology, pathogenesis and treatment of pediatric NAFLD and highlights ongoing challenges and unmet needs in the area.

Entities:  

Year:  2009        PMID: 20556232      PMCID: PMC2885801          DOI: 10.2217/phe.09.21

Source DB:  PubMed          Journal:  Ped Health        ISSN: 1745-5111


  69 in total

1.  Liver biopsy. II. The risk of needle biopsy.

Authors:  N ZAMCHECK; O KLAUSENSTOCK
Journal:  N Engl J Med       Date:  1953-12-24       Impact factor: 91.245

2.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

3.  Decreased prevalence of nonalcoholic fatty liver disease in black obese children.

Authors:  Miriam V Louthan; Judy A Theriot; Ellen Zimmerman; John T Stutts; Craig J McClain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-10       Impact factor: 2.839

4.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

5.  Brachial-ankle pulse wave velocity in Japanese university students.

Authors:  Akiko Shiotani; Mitsugi Motoyama; Tadayuki Matsuda; Teruo Miyanishi
Journal:  Intern Med       Date:  2005-07       Impact factor: 1.271

6.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

7.  A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

Authors:  J B Schwimmer; M S Middleton; R Deutsch; J E Lavine
Journal:  Aliment Pharmacol Ther       Date:  2005-04-01       Impact factor: 8.171

8.  Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients.

Authors:  Kilian Weigand; Kurt Weigand
Journal:  J Gastroenterol Hepatol       Date:  2009-02-09       Impact factor: 4.029

9.  Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

10.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

Authors:  Valerio Nobili; Julie Parkes; Gianfranco Bottazzo; Matilde Marcellini; Richard Cross; Daniel Newman; Francesco Vizzutti; Massimo Pinzani; William M Rosenberg
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

View more
  17 in total

Review 1.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

Review 2.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

3.  Pilot study comparing post-anesthesia care unit length of stay in moderately and severely obese children.

Authors:  Hina Walia; Onur Balaban; Megan Jacklen; Dmitry Tumin; Vidya Raman; Joseph D Tobias
Journal:  J Anesth       Date:  2017-02-27       Impact factor: 2.078

Review 4.  Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit".

Authors:  Michael S Stewart; Margaret J R Heerwagen; Jacob E Friedman
Journal:  Clin Obstet Gynecol       Date:  2013-09       Impact factor: 2.190

5.  Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet.

Authors:  Howard G Shertzer; Sally E Woods; Mansi Krishan; Mary Beth Genter; Kevin J Pearson
Journal:  J Nutr       Date:  2011-02-10       Impact factor: 4.798

Review 6.  MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.

Authors:  Nadia Panera; Daniela Gnani; Annalisa Crudele; Sara Ceccarelli; Valerio Nobili; Anna Alisi
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.

Authors:  Baiyu Yang; Jessica L Petrick; Scott P Kelly; Barry I Graubard; Neal D Freedman; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2017-04-26       Impact factor: 7.396

Review 8.  Valproic acid and nonalcoholic fatty liver disease: A possible association?

Authors:  Edoardo Farinelli; David Giampaoli; Anja Cenciarini; Ephraim Cercado; Alberto Verrotti
Journal:  World J Hepatol       Date:  2015-05-28

9.  A cohort study evaluating the implications of biology, weight status and socioeconomic level on global self-esteem competence among female African-American adolescents.

Authors:  Yolanda M Powell-Young; Jovanny Zabaleta; Cruz Velasco-Gonzalez; Melinda S Sothern
Journal:  J Natl Black Nurses Assoc       Date:  2013-07

10.  Induction of CYP2E1 in non-alcoholic fatty liver diseases.

Authors:  Ghanim Aljomah; Susan S Baker; Wensheng Liu; Rafal Kozielski; Janet Oluwole; Benita Lupu; Robert D Baker; Lixin Zhu
Journal:  Exp Mol Pathol       Date:  2015-11-10       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.